The safety of a novel sublingual rush induction phase for latex desensitization

Current Medical Research and Opinion

Volumn 26, Issue 8, 2010, Pages 1855-1859

  Nettis, Eustachio ^a   Di Leo, Elisabetta ^a   Calogiuri, Gianfranco ^b   Milani, Massimo ^c   Donne, Pantalea Delle ^a   Ferrannini, Antonio ^a   Vacca, Angelo ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b Hospital A Galateo San Cesario di Lecce   (Italy)

^c ALK Abello SpA   (Italy)

Author keywords

Natural rubber latex; Rush protocol; Safety; Sublingual immunotherapy; Tolerability

Indexed keywords

IMMUNOGLOBULIN E; LATEX; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTACT ALLERGY; CONTACT URTICARIA; CONTROLLED STUDY; DESENSITIZATION; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; IMMUNOTHERAPY; MALE; MOUTH; MOUTH ITCHING; PRURITUS; SUBLINGUAL IMMUNOTHERAPY; TONGUE BURNING;

ADMINISTRATION, SUBLINGUAL; ADULT; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNE TOLERANCE; IMMUNIZATION; IMMUNOTHERAPY; LATEX HYPERSENSITIVITY; MALE; MIDDLE AGED; PLACEBOS; RUBBER; URTICARIA; YOUNG ADULT;

EID: 77954756381     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2010.490671     Document Type: Article

References (14)

1. Zak HN, Kaste LM, Schwarzenberger K, et al. Health-care workers and latex allergy. Arch Environ Health 2000;55:336-46
2. Nettis E, Assennato G, Ferrannini A, et al. Type I allergy to natural rubber latex and type IV allergy to rubber chemicals in health care workers with glove related skin symptoms. Clin Exp Allergy 2002;32:441-7
3. Ruëff F, Kienitz A, Schöpf P, et al. Frequency of natural rubber latex allergy in adults is increased after multiple operative procedures. Allergy 2001; 56:889-94
4. Bousquet J, Flahault A, Vandenplas O, et al. Natural rubber latex allergy among health care workers: a systematic review of the evidence. J Allergy Clin Immunol 2006;118:447-54
5. Nettis E, Colanardi MC, Soccio AL, et al. Double-blind, placebo-controlled study of sublingual immunotherapy in patients with latex-induced urticaria: a 12-month study. Br J Dermatol 2007;156:674-81
6. Patriarca G, Nucera E, Pollastrini E, et al. Sublingual desensitization: a new approach to latex allergy problem. Anesth Analg 2002;95:956-60
7. Nettis E, Colanardi MC, Ferrannini A. Type I latex allergy in health care workers with latex-induced contact urticaria syndrome: a follow-up study. Allergy 2004;59:718-23
8. Malling HJ, Weeke B. EAACI immunotherapy position paper. Allergy 1993; 48:9-35
9. Stelmach I, Kaczmarek-Woźniak J, Olszowiec-Chlebna M, Jerzynska J. Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen. Clin Exp Allergy 2009;39:401-8
10. Rossi RE, Monasterolo G. A pilot study of feasibility of ultra-rush (20-25 minutes) sublingual-swallow immunotherapy in 679 patients (699 sessions) with allergic rhinitis and/or asthma. Int J Immunopathol Pharmacol 2005; 18:277-8
11. Nucera E, Schiavino D, Sabato V, et al. Sublingual immunotherapy for latex allergy: tolerability and safety profile of rush build-up phase. Curr Med Res Opin 2008;24:1147-54
12. Frati F, Incorvaia C, Marcucci F, et al. Dose dependence of efficacy but not of safety in sublingual immunotherapy. Monaldi Arch Chest Dis 2006;65:38-40 (Pubitemid 43676458)
13. Gidaro GB, Marcucci F, Sensi L, et al. The safety of sublingual-swallow immunotherapy: an analysis of published studies. Clin Exp Allergy 2005; 35:565-71
14. Sastre J, Fernandez-Nieto M, Rico P, et al. Specific immunotherapy with a standardized latex extract in allergic workers: a double-blind, placebo-controlled study. J Allergy Clin Immunol 2003;111:985-94